Acalabrutinib
Zanubrutinib
(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
Update Venetoclax in CLL
Leukemia & Lymphoma Society
CLL Society
Patient Power
ASH: COVID-19 Resources for Managing Blood Cancers